Williams‑Sonoma insider files to sell 3,153 RSU shares valued at $629K

Rhea-AI Filing Summary

Williams‑Sonoma (WSM) Form 144 disclosure shows a proposed sale of 3,153 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $629,401.86, listed for sale on 09/18/2025 on the NYSE. The shares were acquired as restricted stock units and vested/converted on 09/12/2025 and the filing records payment/consideration as compensation. The filer also reported a prior sale of 4,000 shares on 07/01/2025 that generated $675,847.20 in gross proceeds.

The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer and references Rule 10b5‑1 considerations.

Insights

Securities Analyst

TL;DR: Insiders disposing of newly vested RSUs, modest in size relative to a large-cap issuer; routine disclosure under Rule 144.

The Form 144 indicates a proposed sale of 3,153 shares valued at $629k, acquired as restricted stock units on 09/12/2025 and to be sold via Goldman Sachs on 09/18/2025. The filing is a standard compliance filing rather than a corporate event; the prior July sale of 4,000 shares for $675.8k shows recent insider liquidity. From a market-impact perspective, these transactions are small relative to Williams‑Sonoma's public float

Corporate Governance Expert

TL;DR: Disclosure aligns with insider reporting rules and includes Rule 10b5‑1 language; no governance red flags in the notice itself.

The statement that the seller does not possess undisclosed material information and the inclusion of Rule 10b5‑1 plan adoption fields are standard. The securities were acquired as compensation (RSUs) and the sale appears to be a planned monetization of vested awards. There is no indication in this filing of suspension, investigation, or atypical timing that would suggest governance concerns from this document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	3153	629401.86	122998061	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/12/2025	Acquired as compensation -- Restricted Stock Units	Issuer			3153	09/12/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeff Howie 3250 Van Ness Avenue San Francisco CA 94109	Common Stock	07/01/2025	4000	675847.2

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the WSM Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 3,153 shares of Williams‑Sonoma common stock via Goldman Sachs with an aggregate market value of $629,401.86, to be sold on 09/18/2025 on the NYSE.

How were the shares being sold acquired according to the filing?

The 3,153 shares were acquired as restricted stock units (RSUs) and recorded as acquired on 09/12/2025, with payment/consideration listed as compensation.

Did the filer sell other Williams‑Sonoma shares recently?

Yes, the filing reports a prior sale of 4,000 shares on 07/01/2025 that generated $675,847.20 in gross proceeds.

Which broker will execute the proposed sale?

The sale is listed to be executed through Goldman Sachs & Co. LLC at 200 West Street, New York, NY, on the NYSE.

Does the Form 144 indicate any undisclosed material information or Rule 10b5‑1 plan adoption?

The filer represents they do not know of any undisclosed material adverse information and the form includes the standard Rule 10b5‑1 plan/adoption fields; no plan date is provided in the disclosure.